FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Freenome, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 15, 2026
$12.57+0.82 (+6.98%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.87 (+17.48%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$762.63K
Two years at a glance
Fiscal years 2024 to 2025 and trailing twelve months, USD
Operating income
-$4.33M
Net income
-$762.63K
Reported periodTrailing twelve months